TY - JOUR
T1 - Susceptibility of vancomycin-resistant and –sensitive Enterococcus faecium obtained from Danish hospitals to benzalkonium chloride, chlorhexidine and hydrogen eroxide biocides
AU - Alotaibi, Sulaiman M.I.
AU - Ayibiekea, Alafate
AU - Pedersen, Annemette Frøling
AU - Jakobsen, Lotte
AU - Pinholt, Mette
AU - Gumpert, Heidi
AU - Hammerum, Anette M.
AU - Westh, Henrik
AU - Ingmer, Hanne
PY - 2017/12
Y1 - 2017/12
N2 - Purpose. In Danish hospitals, the number of infections caused by vancomycin-resistant Enterococcus faecium (VRE faecium) has dramatically increased in recent years. Hospital disinfectants are essential in eliminating pathogenic microorganisms, and reduced susceptibility may contribute to hospital-associated infections. We have addressed whether clinical VRE faecium display decreased biocide susceptibility when compared to vancomycin-sensitive Enterococcus faecium (VSE faecium) isolates. Methodology. In total 12 VSE faecium and 37 VRE faecium isolates obtained from Danish hospitals over an extended time period were tested for susceptibility towards three commonly applied biocides, namely benzalkonium chloride, chlorhexidine and hydrogen peroxide. Results. For benzalkonium chloride, 89% of VRE faecium strains had a minimal inhibitory concentration (MIC) of 8mg l–1, whereas for VSE faecium, only 25% of the strains had an MIC of 8mgl–1. For chlorhexidine, the MIC of 95% of VRE faecium strains was 4 mgl–1 or higher, while only 33% of VSE faecium strains displayed MIC values at the same level. In contrast, both VRE and VSE faecium displayed equal susceptibility to hydrogen peroxide, but a higher minimal bactericidal concentration (MBC) was found for the former. The efflux activity was also assessed, and this was generally higher for the VRE faecium strains compared to VSE faecium. Conclusion. VRE faecium from Danish hospitals demonstrated decreased susceptibility towards benzalkonium chloride and chlorhexidine compared to VSE faecium, where the use of chlorhexidine is particularly heavy in the hospital environment. These findings suggest that biocide tolerance may characterize VRE faecium isolated in Danish hospitals.
AB - Purpose. In Danish hospitals, the number of infections caused by vancomycin-resistant Enterococcus faecium (VRE faecium) has dramatically increased in recent years. Hospital disinfectants are essential in eliminating pathogenic microorganisms, and reduced susceptibility may contribute to hospital-associated infections. We have addressed whether clinical VRE faecium display decreased biocide susceptibility when compared to vancomycin-sensitive Enterococcus faecium (VSE faecium) isolates. Methodology. In total 12 VSE faecium and 37 VRE faecium isolates obtained from Danish hospitals over an extended time period were tested for susceptibility towards three commonly applied biocides, namely benzalkonium chloride, chlorhexidine and hydrogen peroxide. Results. For benzalkonium chloride, 89% of VRE faecium strains had a minimal inhibitory concentration (MIC) of 8mg l–1, whereas for VSE faecium, only 25% of the strains had an MIC of 8mgl–1. For chlorhexidine, the MIC of 95% of VRE faecium strains was 4 mgl–1 or higher, while only 33% of VSE faecium strains displayed MIC values at the same level. In contrast, both VRE and VSE faecium displayed equal susceptibility to hydrogen peroxide, but a higher minimal bactericidal concentration (MBC) was found for the former. The efflux activity was also assessed, and this was generally higher for the VRE faecium strains compared to VSE faecium. Conclusion. VRE faecium from Danish hospitals demonstrated decreased susceptibility towards benzalkonium chloride and chlorhexidine compared to VSE faecium, where the use of chlorhexidine is particularly heavy in the hospital environment. These findings suggest that biocide tolerance may characterize VRE faecium isolated in Danish hospitals.
KW - Benzalkonium chloride
KW - Biocide tolerance
KW - Chlorhexidine
KW - Enterococcus faecium
KW - Nosocomial infection
KW - VRE
KW - VSE
U2 - 10.1099/jmm.0.000642
DO - 10.1099/jmm.0.000642
M3 - Journal article
C2 - 29134935
AN - SCOPUS:85037731167
SN - 0022-2615
VL - 66
SP - 1744
EP - 1751
JO - Journal of Medical Microbiology
JF - Journal of Medical Microbiology
IS - 12
M1 - 000642
ER -